• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性细胞通过教育浸润的白细胞产生丝裂原 Gas6 来促进肿瘤生长。

Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6.

机构信息

Vesalius Research Center (VRC), Vlaams Instituut voor Biotechnologie (VIB), Leuven, Belgium.

出版信息

Blood. 2010 Mar 18;115(11):2264-73. doi: 10.1182/blood-2009-06-228684. Epub 2009 Nov 20.

DOI:10.1182/blood-2009-06-228684
PMID:19965679
Abstract

The transforming and tumor growth-promoting properties of Axl, a member of the Tyro3, Axl, and Mer (TAM) family of receptor tyrosine kinases (TAMRs), are well recognized. In contrast, little is known about the role of the TAMR ligand growth arrest-specific gene 6 (Gas6) in tumor biology. By using Gas6-deficient (Gas6(-/-)) mice, we show that bone marrow-derived Gas6 promotes growth and metastasis in different experimental cancer models, including one resistant to vascular endothelial growth factor inhibitors. Mechanistic studies reveal that circulating leukocytes produce minimal Gas6. However, once infiltrated in the tumor, leukocytes up-regulate Gas6, which is mitogenic for tumor cells. Consistent herewith, impaired tumor growth in Gas6(-/-) mice is rescued by transplantation of wild-type bone marrow and, conversely, mimicked by transplantation of Gas6(-/-) bone marrow into wild-type hosts. These findings highlight a novel role for Gas6 in a positive amplification loop, whereby tumors promote their growth by educating infiltrating leukocytes to up-regulate the production of the mitogen Gas6. Hence, inhibition of Gas6 might offer novel opportunities for the treatment of cancer.

摘要

Axl 是 Tyro3、Axl 和 Mer(TAM)受体酪氨酸激酶家族(TAMRs)的成员,其转化和肿瘤促进生长的特性已得到广泛认可。相比之下,人们对 TAMR 配体生长停滞特异性基因 6(Gas6)在肿瘤生物学中的作用知之甚少。通过使用 Gas6 缺陷(Gas6(-/-))小鼠,我们表明骨髓来源的 Gas6 促进了不同实验性癌症模型中的生长和转移,包括一种对血管内皮生长因子抑制剂有抗性的模型。机制研究表明,循环白细胞产生的 Gas6 很少。然而,一旦浸润到肿瘤中,白细胞就会上调 Gas6,这对肿瘤细胞具有有丝分裂作用。与此一致,Gas6(-/-) 小鼠中的肿瘤生长受损可通过移植野生型骨髓来挽救,反之亦然,即将 Gas6(-/-) 骨髓移植到野生型宿主中可模拟肿瘤生长受损。这些发现强调了 Gas6 在正放大环中的一个新作用,即肿瘤通过教育浸润的白细胞上调有丝分裂原 Gas6 的产生来促进自身生长。因此,抑制 Gas6 可能为癌症治疗提供新的机会。

相似文献

1
Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6.恶性细胞通过教育浸润的白细胞产生丝裂原 Gas6 来促进肿瘤生长。
Blood. 2010 Mar 18;115(11):2264-73. doi: 10.1182/blood-2009-06-228684. Epub 2009 Nov 20.
2
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.生长停滞特异性基因 6-Mer 轴在多发性骨髓瘤中的作用。
Leukemia. 2015 Mar;29(3):696-704. doi: 10.1038/leu.2014.236. Epub 2014 Aug 8.
3
TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.TAM 受体 Tyro3 和 Mer 作为结直肠癌的新靶点。
Oncotarget. 2016 Aug 30;7(35):56355-56370. doi: 10.18632/oncotarget.10889.
4
Macrophages give Gas(6) to cancer.巨噬细胞为癌症提供Gas(6)。
Blood. 2010 Mar 18;115(11):2122-3. doi: 10.1182/blood-2009-12-255869.
5
Targeting Gas6/TAM in cancer cells and tumor microenvironment.针对癌细胞和肿瘤微环境中的 Gas6/TAM。
Mol Cancer. 2018 Jan 31;17(1):20. doi: 10.1186/s12943-018-0769-1.
6
AXL/GAS6 signaling governs differentiation of tumor-associated macrophages in breast cancer.AXL/GAS6信号通路调控乳腺癌中肿瘤相关巨噬细胞的分化。
Exp Cell Res. 2025 Jan 1;444(1):114324. doi: 10.1016/j.yexcr.2024.114324. Epub 2024 Nov 6.
7
Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy.来自癌症相关成纤维细胞的 Gas6 促进了化疗期间表达 Axl 的肺癌细胞的迁移。
Sci Rep. 2017 Sep 6;7(1):10613. doi: 10.1038/s41598-017-10873-2.
8
Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.小分子抑制剂可阻断 Gas6 诱导的 TAM 激活和致瘤性。
Sci Rep. 2017 Mar 8;7:43908. doi: 10.1038/srep43908.
9
RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation of hepatocyte growth factor in macrophages.生长停滞特异性蛋白6/mer受体酪氨酸激酶结合后,RhoA/磷脂酰肌醇3激酶/蛋白激酶B/丝裂原活化蛋白激酶信号传导通过上调巨噬细胞中的肝细胞生长因子来促进上皮细胞生长和伤口修复。
J Pharmacol Exp Ther. 2014 Sep;350(3):563-77. doi: 10.1124/jpet.114.215673. Epub 2014 Jun 17.
10
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.Gas6缺乏会增加少突胶质细胞的损失以及小胶质细胞的激活,以应对铜离子螯合剂诱导的脱髓鞘。
J Neurosci. 2008 May 14;28(20):5195-206. doi: 10.1523/JNEUROSCI.1180-08.2008.

引用本文的文献

1
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer.肿瘤相关的MerTK促进促炎微环境并增强三阴性乳腺癌对免疫检查点抑制剂的反应。
Front Oncol. 2025 May 5;15:1579214. doi: 10.3389/fonc.2025.1579214. eCollection 2025.
2
Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?自身免疫性疾病和癌症中TAM受体的蛋白水解作用:它向我们传达了什么信息?
Cell Death Dis. 2025 Mar 5;16(1):155. doi: 10.1038/s41419-025-07480-9.
3
AXL-Mediated Drug Resistance in ALK-Rearranged NSCLC Enhanced by GAS6 From Macrophages and MMP11 Positive Fibroblasts.
巨噬细胞和MMP11阳性成纤维细胞产生的GAS6增强了AXL介导的ALK重排非小细胞肺癌的耐药性。
Cancer Sci. 2025 Apr;116(4):1034-1047. doi: 10.1111/cas.70006. Epub 2025 Feb 4.
4
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.针对肿瘤细胞和巨噬细胞中的 MERTK:一种潜在的干预方法,可用于散发性和 NF2 相关脑膜瘤和神经鞘瘤肿瘤。
Oncogene. 2024 Oct;43(41):3049-3061. doi: 10.1038/s41388-024-03131-z. Epub 2024 Aug 23.
5
Aberrant expressions of TAM receptors are associated with postoperative recurrence in chronic rhinosinusitis with nasal polyps.TAM受体的异常表达与伴鼻息肉的慢性鼻-鼻窦炎术后复发相关。
Eur Arch Otorhinolaryngol. 2024 Jun;281(6):3005-3015. doi: 10.1007/s00405-024-08450-1. Epub 2024 Jan 18.
6
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy.在肝细胞癌中存在癌-胎儿病灶与复发和免疫治疗反应相关。
Nat Cancer. 2024 Jan;5(1):167-186. doi: 10.1038/s43018-023-00672-2. Epub 2024 Jan 2.
7
Soluble TAM Receptor Tyrosine Kinases Correlate with Disease Severity and Predict the Early Responsiveness of Sublingual Immunotherapy in Allergic Rhinitis.可溶性TAM受体酪氨酸激酶与变应性鼻炎的疾病严重程度相关,并可预测舌下免疫治疗的早期反应性。
J Inflamm Res. 2023 Oct 25;16:4845-4855. doi: 10.2147/JIR.S432281. eCollection 2023.
8
TAM family kinases as therapeutic targets at the interface of cancer and immunity.酪氨酸激酶家族作为癌症与免疫交叉领域的治疗靶点。
Nat Rev Clin Oncol. 2023 Nov;20(11):755-779. doi: 10.1038/s41571-023-00813-7. Epub 2023 Sep 4.
9
Editorial: The key role of Mer receptor tyrosine kinase: where inflammation ends and fibrosis begins.社论:Mer受体酪氨酸激酶的关键作用:炎症结束与纤维化开始之处
Front Immunol. 2023 Jul 17;14:1251577. doi: 10.3389/fimmu.2023.1251577. eCollection 2023.
10
Tumour-associated macrophages as a potential target to improve natural killer cell-based immunotherapies.肿瘤相关巨噬细胞作为一种潜在的靶点,以改善基于自然杀伤细胞的免疫治疗。
Essays Biochem. 2023 Sep 28;67(6):1003-1014. doi: 10.1042/EBC20230002.